3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colonic Neoplasms
3
Peritoneal Neoplasms
2
Colorectal Neoplasms
2
Rectal Neoplasms
1
Ovarian Neoplasms
1
Neoplastic Cells, Circulating
1
Melanoma
1
Lymphatic Metastasis
1
Lung Neoplasms
1
Liver Neoplasms
1
Genital Neoplasms, Female
1
Gastrointestinal Stromal Tumors
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Squamous Cell
1
Carcinoma, Merkel Cell
1
Breast Neoplasms
1
Appendiceal Neoplasms
1
Interventions
Gemcitabine
8
Cisplatin
8
pembrolizumab
4
durvalumab
4
Specimen Handling
3
Platinum
3
Oxaliplatin
3
Leucovorin
3
1,2-diaminocyclohexaneplatinum II citrate
3
Taxes
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Folfox protocol
2
Fluorouracil
2
Biopsy
2
Albumin-Bound Paclitaxel
2
130-nm albumin-bound paclitaxel
2
zanidatamab
1
trastuzumab deruxtecan
1
tivozanib
1
peposertib
1
guadecitabine
1
fludarabine
1
dehydroftorafur
1
binimetinib
1
avelumab
1
atezolizumab
1
Trastuzumab
1
Radiation Dose Hypofractionation
1
Radiation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gallbladder Neoplasms
×
Laparoscopy
×
90 days
×
Clear all
No trials found.